Advertisement
Olaparib (Lynparza) monotherapy can provide a significant benefit over standard therapy in women with human epidermal growth factor receptor type 2-negative metastatic breast cancer and a germline BRCA mutation

ASCO: Olaparib Efficacious in BRCA-Related Breast Cancer

0
May offer a new treatment for women with advanced BRCA-related disease, researchers say
The methylene tetrahydrofolate reductase (MTHFR) gene A1298C polymorphism does not appear to be related to methotrexate efficacy or toxicity in patients with rheumatoid arthritis

MTHFR A1298C Polymorphism Not Linked to MTX Outcomes in RA

0
No significant link for MTHFR gene A1298C polymorphism with methotrexate efficacy, toxicity
Polarization-enhanced reflectance and fluorescence imaging is feasible for in vivo intraoperative imaging of nonmelanoma skin cancer

PERFI Feasible for In Vivo Imaging of Nonmelanoma Skin Cancer

0
Methylene blue infused into peritumoral space, and preferentially retained in tumor
Children with type 1 diabetes often have comorbid celiac disease

Comorbid Celiac Disease Common Among Youth With T1DM

0
Prevalence of celiac disease varied from 1.9 to 7.7 percent among children in U.S. and Australia
For effective hand hygiene

Cool Water Works As Well As Hot for Ridding Hands of Germs

0
Time spent scrubbing hands with soap more important that water temperature
A court ruling allowing a civil rights lawsuit against a medical examiner may have serious consequences for physicians in public service

Court Ruling Potentially Threatens Physicians’ Immunity

0
Friend-of-the-court brief reflects concern that the ruling will have negative impact on physicians
Low albumin levels at the start of renal replacement therapy are independently associated with mortality during one-year follow-up

Low Albumin Predicts Mortality in Renal Replacement Therapy

0
Low albumin level is only variable independently associated with mortality during one-year follow-up
For patients with a first demyelinating event (clinically isolated syndrome)

Risk of Conversion to Multiple Sclerosis Down With Minocycline

0
Treatment with minocycline reduces conversion to MS over six months after first demyelinating event
Multidrug-resistant gram-negative bacteria

Drug-Resistant Bacteria Seen in Many Nursing Home Residents

0
More infection-prevention education and policies are needed, researcher says

May 2017 Briefing – Pathology

0
Here are what the editors at HealthDay consider to be the most important developments in Pathology for May 2017. This roundup includes the latest...